Striatal FP-CIT uptake differs in the subtypes of early Parkinson’s disease
暂无分享,去创建一个
U. Dillmann | W. Jost | K. Fassbender | D. Hellwig | C. Kirsch | J. Spiegel | S. Samnick | M. Möllers | W. Jost | M. Möllers
[1] Masanori Ichise,et al. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP , 2002, Movement disorders : official journal of the Movement Disorder Society.
[2] Eileen O. Smith,et al. Decreased single‐photon emission computed tomographic {123I}β‐CIT striatal uptake correlates with symptom severity in parkinson's disease , 1995, Annals of neurology.
[3] W. Oertel,et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. , 2000, Movement disorders : official journal of the Movement Disorder Society.
[4] W. Pirker,et al. Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it? , 2003, Movement disorders : official journal of the Movement Disorder Society.
[5] L. Deecke,et al. [123I]β‐CIT spect in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration , 2000, Movement disorders : official journal of the Movement Disorder Society.
[6] K. Kessler,et al. Differences in age at onset and familial aggregation between clinical types of idiopathic Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.
[7] Marc Laruelle,et al. SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primates , 1993, Synapse.
[8] J. Booij,et al. [123I]FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson's disease , 2001, Journal of Neural Transmission.
[9] E. Wolters,et al. FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson ’ s disease , 2001 .
[10] M. Ichise,et al. SPECT imaging of pre- and postsynaptic dopaminergic alterations in l-dopa–untreated PD , 1999, Neurology.
[11] B. Djahanguiri,et al. The prevention of acute gastric ulcer in the rat by alpha-methyldopa. , 1967, Medicina et pharmacologia experimentalis. International journal of experimental medicine.
[12] Oliver Pogarell,et al. Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3‐month observations , 2003, Movement disorders : official journal of the Movement Disorder Society.
[13] F. Vingerhoets,et al. Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion? , 1997, Annals of neurology.
[14] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[15] C. Marsden,et al. Recent Developments in Parkinson's Disease , 1986 .
[16] S. Asenbaum,et al. [123I]β-CIT and SPECT in essential tremor and Parkinson's disease , 1998, Journal of Neural Transmission.
[17] J O Rinne,et al. Usefulness of a dopamine transporter PET ligand [18F]β-CFT in assessing disability in Parkinson's disease , 1999, Journal of neurology, neurosurgery, and psychiatry.
[18] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[19] M. Sasaki,et al. Differences in the reduced 18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease: correlations with the three main symptoms , 1996, Journal of the Neurological Sciences.
[20] S. Asenbaum,et al. [123I]beta-CIT and SPECT in essential tremor and Parkinson's disease. , 1998, Journal of neural transmission.
[21] Michael G. Stabin,et al. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters , 1997, European Journal of Nuclear Medicine.
[22] T. Robbins,et al. Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[23] Samuel Samnick,et al. FP‐CIT and MIBG scintigraphy in early Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.
[24] D J Wyper,et al. Correlation of Parkinson's disease severity and duration with 123I‐FP‐CIT SPECT striatal uptake , 2000, Movement disorders : official journal of the Movement Disorder Society.
[25] A. Bonnet,et al. [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.